Literature DB >> 31486996

Bloodstream infections in the elderly: what is the real goal?

Yaara Leibovici-Weissman1,2, Noam Tau3,4, Dafna Yahav3,5.   

Abstract

Bloodstream infections (BSI) represent a serious bacterial infection with substantial morbidity and mortality. Population-based studies demonstrate an increased incidence, especially among elderly patients. Controversy exists regarding whether presentation of BSI are different in older patients compared to younger patients; our narrative review of the literature suggests that BSI in elderly patients would probably include one or more of the traditional symptoms/signs of fever, severe sepsis or septic shock, acute kidney injury, and/or leukocytosis. Sources of BSI in older adults are most commonly the urinary tract (more so than in younger adults) and the respiratory tract. Gram-negative bacteria are the most common isolates in the old (~ 40-60% of BSI); isolates from the elderly patient population show higher antibiotic resistance rates, with long-term care facilities serving as reservoirs for multidrug-resistant bacteria. BSI entail significantly higher rates of mortality in older age, both short and long term. Some of the risk factors for mortality are modifiable, such as the appropriateness of empirical antibiotic therapy and nosocomial acquisition of infection. Health-related quality of life issues regarding the elderly patient with BSI are not well addressed in the literature. Utilization of comprehensive geriatric assessment and comprehensive geriatric discharge planning need to be investigated further in this setting and might serve as key for improved results in this population. In this review, we address all these aspects of BSI in old patients with emphasis on future goals for management and research.

Entities:  

Keywords:  Bacteremia; Bloodstream infection; Clinical presentation; Mortality

Mesh:

Year:  2019        PMID: 31486996     DOI: 10.1007/s40520-019-01337-w

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  71 in total

Review 1.  Challenges with Diagnosing and Managing Sepsis in Older Adults.

Authors:  Kalin M Clifford; Eliza A Dy-Boarman; Krystal K Haase; Kristen Maxvill; Steven E Pass; Carlos A Alvarez
Journal:  Expert Rev Anti Infect Ther       Date:  2016-01-14       Impact factor: 5.091

Review 2.  Blood culture-based diagnosis of bacteraemia: state of the art.

Authors:  O Opota; A Croxatto; G Prod'hom; G Greub
Journal:  Clin Microbiol Infect       Date:  2015-01-16       Impact factor: 8.067

Review 3.  Age and immunity: What is "immunosenescence"?

Authors:  Graham Pawelec
Journal:  Exp Gerontol       Date:  2017-10-27       Impact factor: 4.032

4.  Risk factors and mortality for nosocomial bloodstream infections in elderly patients.

Authors:  S Reunes; V Rombaut; D Vogelaers; N Brusselaers; C Lizy; M Cankurtaran; S Labeau; M Petrovic; S Blot
Journal:  Eur J Intern Med       Date:  2011-03-22       Impact factor: 4.487

5.  Population-based burden of bloodstream infections in Finland.

Authors:  K Skogberg; O Lyytikäinen; J Ollgren; J P Nuorti; P Ruutu
Journal:  Clin Microbiol Infect       Date:  2012-04-19       Impact factor: 8.067

6.  Diagnostic accuracy of three different methods of temperature measurement in acutely ill geriatric patients.

Authors:  Katrin Singler; Thomas Bertsch; Hans Juergen Heppner; Robert Kob; Klaus Hammer; Roland Biber; Cornel C Sieber; Michael Christ
Journal:  Age Ageing       Date:  2013-09-13       Impact factor: 10.668

Review 7.  Bacteremia and sepsis in older adults.

Authors:  Timothy D Girard; E Wesley Ely
Journal:  Clin Geriatr Med       Date:  2007-08       Impact factor: 3.076

8.  Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs.

Authors:  Cécile Konrat; Isabelle Boutron; Ludovic Trinquart; Guy-Robert Auleley; Philippe Ricordeau; Philippe Ravaud
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

9.  Incidence of bloodstream infections: a nationwide surveillance of acute care hospitals in Switzerland 2008-2014.

Authors:  Niccolò Buetti; Andrew Atkinson; Jonas Marschall; Andreas Kronenberg
Journal:  BMJ Open       Date:  2017-03-21       Impact factor: 2.692

10.  Factors Associated with Blood Culture Contamination in the Emergency Department: Critical Illness, End-Stage Renal Disease, and Old Age.

Authors:  Chih-Jan Chang; Chi-Jung Wu; Hsiang-Chin Hsu; Chiu-Hui Wu; Fang-Ying Shih; Shou-Wen Wang; Yi-Hui Wu; Chia-Ming Chang; Yi-Fang Tu; Chih-Hsien Chi; Hsin-I Shih
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

View more
  5 in total

Review 1.  FDG PET/CT in Cardiac Infection: Does It Matter? A Narrative Review.

Authors:  Nesrin Ghanem-Zoubi
Journal:  Infect Dis Ther       Date:  2022-07-30

2.  Bacterial behavior in human blood reveals complement evaders with some persister-like features.

Authors:  Stéphane Pont; Nathan Fraikin; Yvan Caspar; Laurence Van Melderen; Ina Attrée; François Cretin
Journal:  PLoS Pathog       Date:  2020-12-16       Impact factor: 6.823

3.  Burden of bloodstream infection in older persons: a population-based study.

Authors:  Kevin B Laupland; Kelsey Pasquill; Lisa Steele; Elizabeth C Parfitt
Journal:  BMC Geriatr       Date:  2021-01-07       Impact factor: 3.921

4.  Prognostic Effects of Inappropriate Empirical Antimicrobial Therapy in Adults With Community-Onset Bacteremia: Age Matters.

Authors:  Yuan-Pin Hung; Po-Lin Chen; Ching-Yu Ho; Chih-Chia Hsieh; Chung-Hsun Lee; Ching-Chi Lee; Wen-Chien Ko
Journal:  Front Med (Lausanne)       Date:  2022-04-11

5.  Trends in Incidence and Outcomes of Hospitalizations for Urinary Tract Infection among Older People in Spain (2001-2018).

Authors:  Domingo Palacios-Ceña; Lidiane Lima Florencio; Valentín Hernández-Barrera; Cesar Fernandez-de-Las-Peñas; Javier de Miguel-Diez; David Martínez-Hernández; David Carabantes-Alarcón; Rodrigo Jimenez-García; Ana Lopez-de-Andres; Marta Lopez-Herranz
Journal:  J Clin Med       Date:  2021-05-26       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.